418 related articles for article (PubMed ID: 26208177)
1. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: A human trial.
Hur JW; Cho TH; Park DH; Lee JB; Park JY; Chung YG
J Spinal Cord Med; 2016 Nov; 39(6):655-664. PubMed ID: 26208177
[TBL] [Abstract][Full Text] [Related]
2. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.
Vaquero J; Zurita M; Rico MA; Aguayo C; Bonilla C; Marin E; Tapiador N; Sevilla M; Vazquez D; Carballido J; Fernandez C; Rodriguez-Boto G; Ovejero M;
Cytotherapy; 2018 Jun; 20(6):806-819. PubMed ID: 29853256
[TBL] [Abstract][Full Text] [Related]
4. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study.
Satti HS; Waheed A; Ahmed P; Ahmed K; Akram Z; Aziz T; Satti TM; Shahbaz N; Khan MA; Malik SA
Cytotherapy; 2016 Apr; 18(4):518-22. PubMed ID: 26971680
[TBL] [Abstract][Full Text] [Related]
5. Combining cell therapy with human autologous Schwann cell and bone marrow-derived mesenchymal stem cell in patients with subacute complete spinal cord injury: safety considerations and possible outcomes.
Oraee-Yazdani S; Akhlaghpasand M; Golmohammadi M; Hafizi M; Zomorrod MS; Kabir NM; Oraee-Yazdani M; Ashrafi F; Zali A; Soleimani M
Stem Cell Res Ther; 2021 Aug; 12(1):445. PubMed ID: 34372939
[TBL] [Abstract][Full Text] [Related]
6. Chronic spinal cord injury treated with transplanted autologous bone marrow-derived mesenchymal stem cells tracked by magnetic resonance imaging: a case report.
Chotivichit A; Ruangchainikom M; Chiewvit P; Wongkajornsilp A; Sujirattanawimol K
J Med Case Rep; 2015 Apr; 9():79. PubMed ID: 25885347
[TBL] [Abstract][Full Text] [Related]
7. Clinical analysis of the treatment of spinal cord injury with umbilical cord mesenchymal stem cells.
Liu J; Han D; Wang Z; Xue M; Zhu L; Yan H; Zheng X; Guo Z; Wang H
Cytotherapy; 2013 Feb; 15(2):185-91. PubMed ID: 23321330
[TBL] [Abstract][Full Text] [Related]
8. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
[TBL] [Abstract][Full Text] [Related]
10. CELLTOP Clinical Trial: First Report From a Phase 1 Trial of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in the Treatment of Paralysis Due to Traumatic Spinal Cord Injury.
Bydon M; Dietz AB; Goncalves S; Moinuddin FM; Alvi MA; Goyal A; Yolcu Y; Hunt CL; Garlanger KL; Del Fabro AS; Reeves RK; Terzic A; Windebank AJ; Qu W
Mayo Clin Proc; 2020 Feb; 95(2):406-414. PubMed ID: 31785831
[TBL] [Abstract][Full Text] [Related]
11. Continuous improvement after multiple mesenchymal stem cell transplantations in a patient with complete spinal cord injury.
Jarocha D; Milczarek O; Wedrychowicz A; Kwiatkowski S; Majka M
Cell Transplant; 2015; 24(4):661-72. PubMed ID: 25807231
[TBL] [Abstract][Full Text] [Related]
12. Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys.
Deng YB; Liu XG; Liu ZG; Liu XL; Liu Y; Zhou GQ
Cytotherapy; 2006; 8(3):210-4. PubMed ID: 16793730
[TBL] [Abstract][Full Text] [Related]
13. Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.
Xiao Z; Tang F; Zhao Y; Han G; Yin N; Li X; Chen B; Han S; Jiang X; Yun C; Zhao C; Cheng S; Zhang S; Dai J
Cell Transplant; 2018 Jun; 27(6):907-915. PubMed ID: 29871514
[TBL] [Abstract][Full Text] [Related]
14. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study.
Albu S; Kumru H; Coll R; Vives J; Vallés M; Benito-Penalva J; Rodríguez L; Codinach M; Hernández J; Navarro X; Vidal J
Cytotherapy; 2021 Feb; 23(2):146-156. PubMed ID: 32981857
[TBL] [Abstract][Full Text] [Related]
16. Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.
Bydon M; Qu W; Moinuddin FM; Hunt CL; Garlanger KL; Reeves RK; Windebank AJ; Zhao KD; Jarrah R; Trammell BC; El Sammak S; Michalopoulos GD; Katsos K; Graepel SP; Seidel-Miller KL; Beck LA; Laughlin RS; Dietz AB
Nat Commun; 2024 Apr; 15(1):2201. PubMed ID: 38561341
[TBL] [Abstract][Full Text] [Related]
17. Co-transplantation of autologous bone marrow mesenchymal stem cells and Schwann cells through cerebral spinal fluid for the treatment of patients with chronic spinal cord injury: safety and possible outcome.
Oraee-Yazdani S; Hafizi M; Atashi A; Ashrafi F; Seddighi AS; Hashemi SM; Seddighi A; Soleimani M; Zali A
Spinal Cord; 2016 Feb; 54(2):102-9. PubMed ID: 26526896
[TBL] [Abstract][Full Text] [Related]
18. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.
Yazdani SO; Hafizi M; Zali AR; Atashi A; Ashrafi F; Seddighi AS; Soleimani M
Cytotherapy; 2013 Jul; 15(7):782-91. PubMed ID: 23731761
[TBL] [Abstract][Full Text] [Related]
19. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
[TBL] [Abstract][Full Text] [Related]
20. The role of nonautologous and autologous adipose-derived mesenchymal stem cell in acute pyelonephritis.
Sabetkish S; Sabetkish N; Talebi MA; Halimi S; Kajbafzadeh AM
Cell Tissue Bank; 2018 Sep; 19(3):301-309. PubMed ID: 29218427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
